Page 2 - Johnc Klock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) have been given an average recommendation of “Hold” by the twenty-six analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and nine have assigned a buy recommendation to […]

Cigna Investments Inc. New purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 2,031 shares of the biotechnology company’s stock, valued at approximately $210,000. Other institutional investors have also made changes […]

Alan B. Lancz & Associates Inc. trimmed its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 27.8% in the fourth quarter, Holdings Channel reports. The fund owned 1,300 shares of the biotechnology company’s stock after selling 500 shares during the period. Alan B. Lancz & Associates Inc.’s holdings in BioMarin Pharmaceutical […]

Comgest Global Investors S.A.S. grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 8.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 136,908 shares of the biotechnology company’s stock after buying an additional 10,493 shares during the quarter. Comgest Global Investors S.A.S. owned 0.07% […]

Tekla Capital Management LLC grew its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 52.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 230,790 shares of the biotechnology company’s stock after acquiring an additional 79,843 shares during the period. […]